Pregnancy and Heart Disease: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 9: Line 9:
{{Editor Help}}
{{Editor Help}}


[[Pregnancy and Heart Disease: Physiology|Physiology]]
==[[Pregnancy and Heart Disease: Epidemiology and Demographics|Epidemiology and Demographics]]==
 
== Epidemiology and Demographics ==
 
* Cardiovascular disease complicates 1- 4% of all pregnancies
 
* Together with DVT/PE has surpassed hemorrhage, infection, and hypertensive disorders as leading cause of maternal mortality (20-30%)
 
* Increasing numbers of women with [[congenital heart disease]] are now reaching childbearing age


==[[Pregnancy and Heart Disease: Physiology|Physiology]]==


   
   

Revision as of 01:14, 20 May 2010

WikiDoc Resources for Pregnancy and Heart Disease

Articles

Most recent articles on Pregnancy and Heart Disease

Most cited articles on Pregnancy and Heart Disease

Review articles on Pregnancy and Heart Disease

Articles on Pregnancy and Heart Disease in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Pregnancy and Heart Disease

Images of Pregnancy and Heart Disease

Photos of Pregnancy and Heart Disease

Podcasts & MP3s on Pregnancy and Heart Disease

Videos on Pregnancy and Heart Disease

Evidence Based Medicine

Cochrane Collaboration on Pregnancy and Heart Disease

Bandolier on Pregnancy and Heart Disease

TRIP on Pregnancy and Heart Disease

Clinical Trials

Ongoing Trials on Pregnancy and Heart Disease at Clinical Trials.gov

Trial results on Pregnancy and Heart Disease

Clinical Trials on Pregnancy and Heart Disease at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Pregnancy and Heart Disease

NICE Guidance on Pregnancy and Heart Disease

NHS PRODIGY Guidance

FDA on Pregnancy and Heart Disease

CDC on Pregnancy and Heart Disease

Books

Books on Pregnancy and Heart Disease

News

Pregnancy and Heart Disease in the news

Be alerted to news on Pregnancy and Heart Disease

News trends on Pregnancy and Heart Disease

Commentary

Blogs on Pregnancy and Heart Disease

Definitions

Definitions of Pregnancy and Heart Disease

Patient Resources / Community

Patient resources on Pregnancy and Heart Disease

Discussion groups on Pregnancy and Heart Disease

Patient Handouts on Pregnancy and Heart Disease

Directions to Hospitals Treating Pregnancy and Heart Disease

Risk calculators and risk factors for Pregnancy and Heart Disease

Healthcare Provider Resources

Symptoms of Pregnancy and Heart Disease

Causes & Risk Factors for Pregnancy and Heart Disease

Diagnostic studies for Pregnancy and Heart Disease

Treatment of Pregnancy and Heart Disease

Continuing Medical Education (CME)

CME Programs on Pregnancy and Heart Disease

International

Pregnancy and Heart Disease en Espanol

Pregnancy and Heart Disease en Francais

Business

Pregnancy and Heart Disease in the Marketplace

Patents on Pregnancy and Heart Disease

Experimental / Informatics

List of terms related to Pregnancy and Heart Disease

Cardiology Network

Discuss Pregnancy and Heart Disease further in the WikiDoc Cardiology Network
Adult Congenital
Biomarkers
Cardiac Rehabilitation
Congestive Heart Failure
CT Angiography
Echocardiography
Electrophysiology
Cardiology General
Genetics
Health Economics
Hypertension
Interventional Cardiology
MRI
Nuclear Cardiology
Peripheral Arterial Disease
Prevention
Public Policy
Pulmonary Embolism
Stable Angina
Valvular Heart Disease
Vascular Medicine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [3] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Epidemiology and Demographics

Physiology

History and Symptoms

Often accompanied by symptoms of fatigue, decreased exercise capacity, hyperventilation, dyspnea, palpitations, lightheadedness, and even syncope. Leg edema is often observed late in pregnancy and can lead to an erroneous diagnosis of heart failure. The arterial pulsese are full and collapsing and are similar to those palpated in patiends with aortic insufficiency or hyperthyroidism.


Physical Examination

  1. Increased first heart sound
  1. Persistent split S2
  1. Third heart sound is uncommon
  1. Pulmonic midsystolic murmur
  1. Continuous murmur (mammary soufflé, cervical hum)
  1. Varicosities and ankle edema
  1. In general there are often innocent murmurs of pregnancy. These are the result of a hyperkinetic circulation. These murmurs are usually midsystolic and soft and heard best at the left lower sternal border and over the pulmonic area.


Laboratory Findings

Electrocardiogram

  • The QRS axis may shift either to the left or the right, but usually lies within normal limits.


Chest X Ray

  • The pelvic area should be shielded if a chest x-ray is done. The heart may seem enlarged due to elevation of the diaphragm and this should be interpreted with caution.


MRI and CT

  • MRI: There are no known safety hazards but the experience with the technique is limited. Currently the FDA recommends prudence in using MRI during pregnancy.


Echocardiography or Ultrasound

  • Echo: There is a progressive increase in chamber dimension with approximately a 20% increase in the size of the right atrium and the right ventricle, a 12% increase in left atrial size, and a 6% increase in left ventricular size. Postpartum, the changes gradually returned to baseline. In addition, there is early and progressive dilation of the mitral, tricuspid, and pulmonary annuli which is associated with an increase in valvular regurgitation.
  • Fetal Echo:
  1. Risk factors for structural heart disease (i.e. who to ECHO):
    • women with a history of congenital heart disease themselves or in previous children
    • diabetes and collagen vascular disease predispose to congenital heart disease
    • a history of a fetal arrhythmia
    • consumption of teratogens

  1. Fetal ECHO
    • one study found a sensitivity of 96% in detecting major structural malformations (72/74 abnormalities identified among 1,022 fetuses)
    • useful for management during pregnancy, postpartum, and genetics counseling


Other Diagnostic Studies

  • Exercise stress testing: If this is done, there should be fetal monitoring.
  • Radiation: If the patient receives less than five rads, then they can be reassured a very likelihood of risk. If they received more than 15 rads, termination of the pregnancy is recommended. Routine chest x-ray is associated with radiation of 20 millirads to the chest. Standard fluoroscopy delivers 1-2 rads per minute. Cineangiography delivers 5-10 rads per minute. Only 5% of the radiation delivered is absorbed by the fetus. A lead apron should be used over the mother's pelvis. With the use of nuclear medicine procedures the radiopharmaceuticals collect in the bladder when the placenta is directly across from the fetus. The expected radiation with thallium-201 or Tc imaging is less than one rad per examination.
  • Pulmonary artery catheterization: Hemodynamic monitoring can be of great help in managing high-risk patients during pregnancy, labor, delivery, and the postpartum period. The pulmonary artery line should be placed without fluoroscopic guidance. Insertion is recommended throughout labor and delivery for any patient with symptomatic cardiac disease during pregnancy or with the potential for deterioration due to valvular, myocardial, or ischemic heart disease. Hemodynamic monitoring should be continued for at least several hours after delivery to ensure stability.
  • Cardiac catheterization: May be indicated in rare instances of cardiac decompensation. To minimize radion to the pelvic and abdominal areas, the brachial, rather than the femoral approach is preferred.


Pharmacotherapy

Antibiotic prophylaxis:

The official American Heart Association (AHA) recommendation is that antibody prophylaxis is not necessary for an uncomplicated delivery except among patients with a prosthetic heart valve or surgically constructed systemic to pulmonary shunt. However, because of the difficulties in predicting complicated deliveries and the potential devastating consequences of endocarditis, antibiotic prophylaxis for vaginal delivery in all patients with congenital heart disease expect those with an isolated secundum type atrial septal defect and those six months or more after repair of septal defects or surgical ligation division of a patent duct is arteriosus, seems reasonable. At the time of delivery it is recommended that all women with valvular disease receive antibiotics, usually penicillin (PCN) and gentamycin. For those with a PCN allergy, vancomycin is used.


Specific Disease States

Aortic Stenosis

  • Most commonly bicuspid valve
  • Patients with mild to moderate severity do very well
  • Severe cases have maternal mortality up to 17% and fetal mortality up to 32%
  • Critical cases need surgery / valvuloplasty


Congenital Heart Disease in Pregnancy

Overview

  • Rapidly becoming most common cardiac problem among pregnant patients
    • Improved diagnostic techniques
    • Availability of corrective surgery
  • Children of affected mothers at increased risk of having similar lesions
  • Outcomes clearly linked to functional status pre-pregnancy


Classification of disease

Can classify lesions into 3 classes:


Volume Overload (L-->R shunt)
    • PVR and SVR falls to same degree
    • Degree of shunting does not change
    • Maternal and fetal mortality ≥50%
  • Consider termination if detected early
  • Careful medical management
-Supplemental O2 during pregnancy
-Hospitalization at 20 weeks gestation
-Prompt treatment of CHF
-Avoid shifts in preload/afterload
Atrial Septal Defect (ASD): Arrhythmias, thromboembolism may develop among pregnant women with an ASD. However, there is no available evidence to suggest that pregnant patients should be managed differently from nonpregnant patients with respect to the indications for ASD closure are no different in pregnant women compared to non-pregnant women.
Pressure Overload
  • Pulmonic Stenosis
    • Degree of obstruction determines outcome
    • Gradient >80 mm Hg mandates correction
    • Accounts for 9% of all congenital disease in adults
    • Class I or II patients usually do well
    • HTN needs careful management
    • Early to mid pregnancy,  C.O. and end-diastolic dimension ↓ outflow tract obstruction (counteracted by SVR)
  • Avoid Valsalva
  • Encourage left lateral decubitus position
    • Maximum risk period during delivery when blood loss can result in increased gradient + systemic hypotension
  • Keep well hydrated
  • Avoid digoxin, simpathomimetics and excessive diuretics


Cyanotic Heart Disease (R-->L shunt)[1]
  • Poor prognosticators:
    • Hematocrit > 60%
    • O2 sat<85%
  • Livebirth 12% vs. 92% is sat >90%
    • Systemic RV pressures
    • Drop in SVR leads to increased shunting, deeper cyanosis and rising HCT
    • Need to avoid Valsava during delivery
    • Maternal mortality more than 4%


Marfan's Syndrome

  • Autosomal dominant inheritance pattern (counseling is essential)
  • Most common in 3rd trimester or 1st stage of labor
  • Increases with enlarging aortic root diameter
  • Surgery recommended pre-conception if root diameter >40 mm
  • Surgery recommend during gestation if > 55 mm
  • Close follow-up with serial echo


Mitral Stenosis

Overview


  • Most hemodynamically important valvular problem during pregnancy
  • Physiologic changes result in increased pulse and C.O. with augmentation of diastolic gradient


Management of MS in Pregnancy


  • Restriction of physical activity and salt intake. Avoid supine position
  • Diuretics if necessary (gentle)
  • Consideration of invasive monitoring
  • Replace blood losses during delivery carefully
  • Percutaneous Balloon Mitral Valvuloplasty can be performed during pregnancy if necessary (Class III,IV)


Myocardial Infarction

Overview

  • First reported case in 1922
  • Incidence ~1/10000
  • Ages range 16-45
  • Most common in 3rd trimester women > 33 years of age
  • Anterior wall most commonly involved
  • Maternal mortality 21% (most at time of MI or within 2 weeks- usually with labor and delivery)
  • Outcomes better if MI early in pregnancy
  • Fetal deaths usually associated with maternal deaths
  • Risk factors:
  • FH of CAD
  • Low HDL
  • High LDL
  • Smoking
  • Previous OCP use


Pathophysiology

  • Caths in 54% of published cases:
  • CAD with or without thrombus 43% (58% in prepartum period)
  • Thrombus without CAD 21%
  • Normal coronaries 29% (75% in peripartum period MIs)
  • Coronary dissection 16% (33% in postpartum period)


Diagnosis

  • EKG and enzymes are the gold standard
  • 37% of patients undergoing elective C-section have EKG changes suggestive of MI or ischemia
  • Echo to assess regional wall motion abnormalities can be useful
  • Nuclear imaging and diagnostic cath exposure to conceptus <0.01 Gy (0.05 Gy considered to be threshold value)


Drugs

Check with pharmacist or Maternal Fetal Medicine Specialist before any drug administration


  • Nitrates – use low dose to prevent fetal distress
  • Morphine sulfate
  • Thrombolytics mostly untested
  • Streptokinase does not cross placental membrane in animals, but Ab found in neonatal spinal cord fluid
  • Risk for maternal hemorrhage (1 case of placental abruption reported); increased risk when given at time of delivery
  • Delivery best delayed at least 2-3 weeks


Peripartum Cardiomyopathy

Diagnostic criteria (Demakis et al, 1971)

  • Development of CHF/LV dysfunction in last month of pregnancy to 5 months postpartum
  • Absence of determinable cause
  • Absence of demonstrable cardiac disease before last month of pregnancy


Common Mimickers

  • Accelerated HTN
  • Infection/sepsis
  • Diastolic dysfunction
  • High output state of pregnancy


Demographics

  • Estimates of incidence 1/1300-15000
  • Previous studies likely overestimated
  • More common in women with:
  • Multiple pregnancies
  • African decent
  • h/o toxemia
  • Long-term tocolytic use
  • Age>30
  • Twin Pregnancy
  • Etiology remains unknown
  • Signs and sxs similar to those of nl pregnancy


Hemodynamic findings

Chamber Normal Pregnancy Peripartum CMP
RA 2 11 (2-34)
PA 11 39 (18-62)
PCW 6 18 (5-32)
CO (L/min) 7 6 (5-9)
HR 83 104 (76-142)


Treatment of Peripartum CMP


Outcome of Peripartum CMP

  • Mortality 25-50% (half deaths in first 3 months)
  • Remainder stable/recover within 6 months
  • Can recur with subsequent pregnancies
  • Favorable outcomes with cardiac transplantation


Managing Prosthetic Valves During Pregnancy[2]

  • Coumadin use during 1st trimester associated with warfarin embryopathy
  • Coumadin use in other trimesters postulated to cause CNS abnormalities
  • Keeping Coumadin dose ≤ 5.0 mg/day appears safe
  • Recommendations based more on opinion than scientific evidence
  • SBE Prophylaxis at Delivery


Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy[3]

  • In women with prosthetic heart valves, the guideline developers recommend:


  1. Adjusted-dose, twice-daily LMWH throughout pregnancy in doses adjusted either to keep a 4-hour postinjection anti-Xa heparin level at approximately 1.0 to 1.2 U/mL (preferable) or according to weight (Grade 1C), or
  1. Aggressive adjusted-dose UFH throughout pregnancy: i.e., administered SC every 12 hours in doses adjusted to keep the mid-interval aPTT at least twice control or to attain an anti-Xa heparin level of 0.35 to 0.70 U/mL (Grade 1C), or
  1. UFH or LMWH (as above) until the thirteenth week, change to warfarin until the middle of the third trimester, and then restart UFH or LMWH (Grade 1C).
Remark: Long-term anticoagulants should be resumed postpartum with all regimens
  1. In women with prosthetic heart valves at high risk, the guideline developers suggest the addition of low-dose aspirin, 75 to 162 mg/day (Grade 2C).


Regurgitant Valvular Lesions During Pregnancy

  • Usually tolerated very well during pregnancy
  • Severity may decrease during pregnancy due to drop in SVR
  • Antibiotic prophylaxis important if infection suspected


Rheumatic Cardiac Disease in Pregnancy

  • Previously accounted for over 90% of CV disease during pregnancy
  • Recent studies show congenital disease now more common
  • Royal Infirmary at Edinburgh University: 94% (1928-47), 36% (68-77), 24% (73-77)
  • Remains common in less developed nations


Pulmonary Hypertension in Pregnancy

  • High maternal / perinatal mortality (~50%)
  • Vaginal delivery with limited anesthetics are preferred.


Resuscitation in Late Pregnancy

Cardiac arrest occurs in approximately one in 30,000 women in late pregnancy.[4] Maternal mortality is caused by venous thromboembolism, severe preeclampsia or eclampsia, sepsis, amniotic fluid embolism, haemorrhage, trauma, iatrogenic causes including anaesthesia and drug errors or allergy, and congenital or acquired heart disease.[5]


Consideration of urgent hysterotomy or Caesarean section should be made for the pregnant woman who has a cardiac arrest. If early resuscitation fails, birth of the fetus may improve maternal and fetal chance of survival. Infants over 24-25 weeks gestation have the best chance of survival if birthed within 5 minutes of maternal cardiac arrest. It is recommended that hysterotomy or Caesarean section be commenced 4 minutes after a cardiac arrest unless there has been a successful resuscitation and maternal perfusion restored within that time.[6]


Obesity exaggerates the risks and physical changes in pregnant women.[4]


Position of the pregnant women

  • Position the women on her back with the shoulders flat. Place padding/wedge under the right buttock to give an obvious pelvic tilt to the left.[7]
  • The thighs of a rescuer may be used for resting the women on, and providing a lateral tilt.[4]
  • An assistant may move the uterus further off the vena cava by lifting the uterus with two hands to the left and towards the woman’s head.[4]


Airway management

  • The woman should be inclined laterally for suction, removing ill-fitting dentures or foreign bodies, and inserting airways.[4]
  • Mouth to mouth or bag and mask ventilation is done with a pillow; the head and neck are fully extended.
  • Apply cricoid pressure until the airway is protected by a cuffed tracheal tube if sufficient staff are available to do this – this decreases risk of gastric aspiration.[6]
  • A soon as possible tracheal intubation should be inserted – ensures adequate ventilation with increased intra-abdominal pressure.[6]
  • Consider using a smaller tracheal tube if the airway is narrowed due to oedema and swellling.[6]
  • Positioning for intubation - using one pillow helps to flex the neck and extend the head.[4]


Circulation management

  • Adhesive defibrillator pads attachment are used to assist contact which may be difficult due to the larger breasts in the pregnant woman.[6]
  • Hand position higher than the normal position for chest compressions may be needed to adjust for the elevation of the diaphragm and abdominal contents due to the gravid uterus.[6]
  • Raising the woman’s legs will assist venous return.[4]


Gastrointestinal management

Early intubation decreases the risk of gastric aspiration.[6]


Intiating caesarean section

Immediately a pregnant woman collapses and requires resuscitation a staff member should collect the Caesarean Section Perimortem pack.


References

  1. Presbitero P. et al. Circulation 1994;89:2673-6.
  2. Vitale N., et al. JACC 1999;33:1637-41.
  3. Bates S.M. et al. Chest 2004;126:627S-44S.
  4. 4.0 4.1 4.2 4.3 4.4 4.5 4.6 Morris S, Stacey M. Resuscitation in pregnancy. BJM 2003;327:1277-1279.
  5. Mallampalli A, Powner DJ, Gardner MO. Cardiopulmonary resuscitation and somatic support of the pregnant patient. Critical Care Clinics,. 2004;20:747-761.
  6. 6.0 6.1 6.2 6.3 6.4 6.5 6.6 Soar J, Deakin CD, Nolan JP, Abbas G, Alfonzo A, et al. European Resuscitation Council Guidelines for Resuscitation 2005. Section 7. Cardiac arrest in special circumstances. Resuscitation 2005;6751:S135-S170.
  7. Australian Resuscitation Council. Guideline 7 Cardiopulmonary resuscitation. In: Australian Resuscitation Council Guidelines; 2006.


Sources:


Acknowledgements

The content on this page was first contributed by C. Michael Gibson M.S., M.D.


Template:SIB



Template:WikiDoc Sources